{
  "meta": {
    "title": "Sle_And_Antiphospholipid_Syndrome",
    "url": "https://brainandscalpel.vercel.app/sle-and-antiphospholipid-syndrome-8ca5ff45.html",
    "scrapedAt": "2025-11-30T08:49:18.347Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Sjogren syndrome</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Systemic lupus erythematosus </span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Antiphospholipid syndrome</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">30 years old female presents with 2 years history of malar rash, multiple joint pain and oral ulcer. Investigation reveals leukopenia, Anti-nuclear antibody is strongly positive and anti-dsDNA antibody is high titer positive what is the most likely diagnosis?</span></p>",
      "unique_key": "DT1295564",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295564,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>High titer dsDNA is specific for diagnosis of systemic Lupus erythematosus. Malar rash, polyarthritis with high titer anti-dsDNA antibody confirms the diagnosis of systemic Lupus Erythematosus.</p>\r\n<p><strong>Must know facts about SLE:</strong></p>\r\n<p><strong>a) Risk factor: </strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250110985a50bb-e7cc-4490-9238-747bbbe63f68.jpg\">\r\n<p><strong>b) Female sex and SLE- </strong>Oestradiol binds to receptors on T and B lymphocytes, increasing activation and survival of those cells, especially autoreactive subsets, thus favouring prolonged immune responses. Genes on the X chromosome that influence SLE, such as TREX1, may play a role in gender predisposition, possibly because some genes on the second X in females are not silent.</p>\r\n<p><strong>c)</strong> People with XXY karyotype (Klinefelter's syndrome) have a significantly increased risk for SLE.</p>\r\n ",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-smith antibody </span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-histone antibody </span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-nuclear antibody </span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti ds-DNA antibody</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following antibody is considered specific for diagnosis of systemic Lupus Erythematosus?</span></p>",
      "unique_key": "DT1295926",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295926,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Antinuclear antibody:</strong> most sensitive screening test in suspected cases of systemic lupus erythematosus.</p>\r\n<p><strong>Anti histone antibody-</strong> though seen in Systemic lupus erythematosus but more frequently seen in drug induced lupus.</p>\r\n<p>Anti-dsDNA antibody is specific for diagnosis of SLE only in high titres.</p>\r\n<p>Hence</p>\r\n<p>High-titer IgG antibodies to double-stranded DNA and antibodies to the Sm antigen are both specific for SLE and therefore, Favor the diagnosis in the presence of compatible clinical manifestations<em>.</em></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011078fa3885-74b5-435a-aba3-8b9bdf0aca4a.jpg\">\r\n ",
      "correct_choice_id": 11,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Butterfly rash or malar rash is form of chronic dermatitis.</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Only 20% of patients with discoid lupus erythematosus (DLE) have systemic lupus erythematosus.</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-dsDNA antibody is associated with subacute cutaneous erythematosus</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above. </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is Incorrect about cutaneous manifestations of systemic lupus erythematosus?</span></p>",
      "unique_key": "DT1295927",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295927,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Cutaneous Manifestations of Systemic lupus erythematosus:</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250110015d2143-aceb-42b7-a8d8-d4dd795059e3.png\">\r\n ",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Mesangial proliferative Glomerulonephritis </span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Focal lupus nephritis </span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Minimal mesangial Glomerulonephritis.</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Membranous lupus nephritis </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following subtype of lupus nephritis has highest risk of progression to Chronic kidney disease and hence requires aggressive Immunosuppressive therapy?</span></p>",
      "unique_key": "DT1295929",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295929,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Important terminology related to renal pathology in lupus nephritis:</strong></p>\r\n<ul>\r\n<li>A-stands for active while C stands for chronic</li>\r\n<li>Focal stands for involvement of &lt;50% glomeruli while diffuse stands for &gt;50% glomeruli.</li>\r\n<li>Segmental means &lt;50% of a glomerulus is involved while global means&gt;50% of a glomerulus is involved.</li>\r\n<li>Antibodies that have shown relation to nephritis in SLE include anti-dsDNA antibody, anti C1Q antibody</li>\r\n</ul>\r\n<p>Classification of Lupus Nephritis (International Society of Nephrology and Renal Pathology Society)</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250110dd15861a-7874-483e-be5e-a462d0ab26ac.png\">\r\n ",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Anaemia of chronic disease</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Autoimmune haemolytic anemia</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Leukopenia</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Lymphopenia </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is most common Haematological manifestation of systemic lupus erythematosus?</span></p>",
      "unique_key": "DT1295931",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295931,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011007f565f9-ab5a-4c36-9517-42d3ddf28afc.png\">\r\n ",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Mycophenolate mofetil </span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Tacrolimus</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Azathioprine </span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclophosphamide </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following immunosuppressant is drug of choice for initial therapy in life/organ threatening forms of lupus nephritis?</span></p>",
      "unique_key": "DT1295932",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295932,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>So it has to be kept in mind that if question is first drug to be given in life threatening forms of SLE then answer is high dose glucocorticoids.</p>\r\n<p>Any inflammatory life-threatening or organ-threatening manifestations of SLE is systemic glucocorticoids (0.5-1 mg/kg per day PO or 500-1000 mg of methylprednisolone sodium succinate IV daily for 3 days followed by 0.5-1 mg/kg of daily prednisone or equivalent).</p>\r\n<p><strong>Cytotoxic therapy :</strong></p>\r\n<p>For initial therapy( called induction phase)-Cyclophosphamide&gt; mycophenolate mofetil</p>\r\n<p>For maintenance therapy<strong>- </strong><strong>azathioprine or mycophenolate mofetil</strong></p>\r\n<p>Irrespective of cytotoxic therapy, all SLE patients with life threatening or organ threatening manifestation should receive hydroxychloroquine.</p>\r\n ",
      "correct_choice_id": 54,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-dsDNA antibody</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Smith antibody </span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Antiphospholipid antibody</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti Ro antibody</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following autoantibody in SLE is considered pathogenic for development of neonatal heart block?</span></p>",
      "unique_key": "DT1295933",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295933,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Anti Ro antibody is considered pathogenic for development of congenital heart block.</p>\r\n<p><strong>Neonatal lupus:</strong></p>\r\n<p>Ro antibody is associated with neonatal lupus consisting of rash and/or congenital heart block with or without cardiomyopathy. The cardiac manifestations can be life-threatening; therefore, the presence of anti-Ro requires vigilant monitoring of fetal heart rates with prompt intervention (delivery if possible) if distress occurs. Hydroxychloroquine treatment of an anti-Ro-positive mother whose prior infant developed congenital heart block significantly reduces the chance that subsequent foetuses will develop heart block. Dexamethasone treatment of a mother in whom fetal first- or second-degree heart block is detected in utero sometimes prevents progression of heart block.</p>\r\n ",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Procainamide </span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">TNF inhibitors </span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Leflunomide</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Propylthiouracil </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drug/drug is not associated with drug induced lupus?</span></p>",
      "unique_key": "DT1295935",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295935,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Drug induced Lupus:</strong></p>\r\n<ul>\r\n<li>This is a syndrome of positive ANA associated with symptoms such as fever, malaise, arthritis or intense arthralgias/myalgias, serositis, and/ or rash.</li>\r\n<li><strong>Has less female predilection than SLE, rarely involves kidneys or brain, is rarely associated with anti-dsDNA, is commonly associated with antibodies to histone</strong></li>\r\n<li>Among the most frequent are the antiarrhythmics procainamide, disopyramide, and propafenone; the antihypertensive hydralazine; several angiotensin-converting enzyme inhibitors and beta blockers; the antithyroid propylthiouracil; the antipsychotics chlorpromazine and lithium; the anticonvulsants carbamazepine and phenytoin; the antibiotics isoniazid, minocycline, and nitrofurantoin, the antirheumatic sulfasalazine; the diuretic hydro- chlorothiazide; and the antihyperlipidemics lovastatin and simvastatin.</li>\r\n<li>Biologics that can cause drug-induced lupus (DIL) include inhibitors of IFNs and TNF.</li>\r\n<li>ANA usually appears before symptoms; however, many of the medications mentioned above induce ANA in patients who never develop symptoms of drug-induced lupus.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Systemic lupus erythematous </span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital thrombophilia </span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">TORCH infection </span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-phospholipid syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">30 years old female presents with recurrent second trimester abortion (3 consecutive). There is no other symptom. ANA is negative and lupus anticoagulant is positive twice tested 12 weeks apart. what is the most likely diagnosis?</span></p>",
      "unique_key": "DT1295936",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295936,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Antiphospholipid syndrome (APS)</strong> is an autoantibody-mediated acquired thrombophilia characterized by recurrent arterial or venous thrombosis and/or pregnancy morbidity. It affects primarily females.</li>\r\n<li>APS may occur alone (primary) or in association with other auto- immune diseases, mainly systemic lupus erythematosus (SLE) (secondary). <strong>Catastrophic APS (CAPS)</strong> is a life-threatening rapidly progressive thromboembolic disease involving simultaneously three or more organs.</li>\r\n<li>The diagnosis of APS should be seriously considered in cases of thrombosis, cerebral vascular accidents in individuals &lt;55 years of age, or pregnancy morbidity in the presence of livedo reticularis or thrombocytopenia.</li>\r\n<li><strong>The Diagnosis of antiphospholipid syndrome presence of atleast one clinical and one laboratory criteria. </strong></li>\r\n<li>Clinical criteria include (1) vascular thrombosis, defined as one or more clinical episodes of arterial, venous, or small vessel thrombosis in any tissue or organ; and (2) pregnancy morbidity, defined as (a) one or more unexplained deaths of a morphologically normal foetus at or beyond the 10th week of gestation; (b) one or more premature births of a morphologically normal neonate before the 34th week of gestation because of eclampsia, severe preeclampsia, or placental insufficiency; or (c) three or more unexplained consecutive spontaneous abortions before the 10th week of gestation.</li>\r\n<li>Laboratory criteria include (1) LA, (2) anticardiolipin (aCL), and/or (3) anti-&beta;2GPI antibodies, at intermediate or high titers on two occasions 12 weeks apart.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti B2GP1 </span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Anticardiolipin antibody </span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Lupus anticoagulant </span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-ribosomal P Antibody. </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a criteria antiphospholipid antibody?</span></p>",
      "unique_key": "DT1295937",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295937,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501108a2f14ee-dc09-4d4d-8df1-b2d29547b711.jpg\">\r\n ",
      "correct_choice_id": 94,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Heparin </span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin </span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydroxychloroquine </span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Apixaban</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Drug of choice for management of antiphospholipid syndrome in pregnancy?</span></p>",
      "unique_key": "DT1295938",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295938,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Treatment of Antiphospholipid syndrome: </strong></p>\r\n<ul>\r\n<li>Lifelong anticoagulation in case of vascular thrombosis. Drug of choice for this is warfarin as newer oral anticoagulants have not been approved for treatment of thrombotic APS.</li>\r\n<li>In patients of antiphospholipid syndrome with only pregnancy morbidity, anticoagulation is given only during pregnancy and 6-12 weeks postpartum. Warfarin is associated with congenital anomalies, hence it is not used during pregnancy.</li>\r\n<li>If antiphospholipid syndrome is diagnosed in patients of SLE (then it is called as secondary APS) then Hydroxychloroquine is to be given to all patients.</li>\r\n<li>Administration of direct oral thrombin inhibitors recently has been shown to increase the risk of arterial events, especially in patients with triple positivity or previous arterial thrombosis.</li>\r\n</ul>\r\n<p><strong>Warfarin Embryopathy:</strong></p>\r\n<p>Warfarin exposure in the first trimester can lead to an embryopathy known as fetal warfarin syndrome (FWS), characterised by <strong>nasal hypoplasia and skeletal abnormalities, including short limbs and digits, and stippled epiphyses</strong>. The critical risk period for FWS has not been definitively confirmed but is thought likely to span gestational weeks 6 to 12.</p>\r\n<p>There is some evidence that the risk of FWS may be dose-dependent, with doses of &gt;5mg carrying a higher risk, although doses lower than this are not without risk.</p>\r\n ",
      "correct_choice_id": 101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}